|
SH3D19 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.935000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.666800E-01 |
| Normal-vs-Stage2 |
9.693600E-01 |
| Normal-vs-Stage3 |
1.487820E-01 |
| Normal-vs-Stage4 |
1.757530E-02 |
| Stage1-vs-Stage2 |
6.259000E-01 |
| Stage1-vs-Stage3 |
3.708400E-01 |
| Stage1-vs-Stage4 |
1.925800E-01 |
| Stage2-vs-Stage3 |
3.112000E-01 |
| Stage2-vs-Stage4 |
1.541420E-01 |
| Stage3-vs-Stage4 |
4.865200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.144000E-01 |
| Normal-vs-AfricanAmerican |
1.731360E-01 |
| Normal-vs-Asian |
1.364170E-02 |
| Caucasian-vs-AfricanAmerican |
3.127200E-01 |
| Caucasian-vs-Asian |
1.334580E-01 |
| AfricanAmerican-vs-Asian |
1.660570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.995840E-01 |
| Normal-vs-Female |
8.036800E-01 |
| Male-vs-Female |
4.377600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.936000E-02 |
| Normal-vs-Extreme_Weight |
1.107810E-01 |
| Normal-vs-Obese |
5.602600E-01 |
| Normal-vs-Extreme_Obese |
3.382600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.204600E-01 |
| Normal_Weight-vs-Obese |
2.245600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.178800E-01 |
| Extreme_Weight-vs-Obese |
2.176000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.997400E-01 |
| Obese-vs-Extreme_Obese |
6.230400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.206400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.225600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.632630E-01 |
| Normal-vs-Age(81-100Yrs) |
8.077400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.040800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.344200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.147000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.318400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.818400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.326600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.619000E-01 |
| Normal-VS-Type2 PRCC |
2.783200E-01 |
| Normal-VS-KIRP CIMP |
6.957800E-03 |
| Normal-VS-Unclassified PRCC |
7.411400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.814200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.125700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.308600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.460400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.686600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.479890E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.224770E-01 |
| Normal-vs-N1 |
3.067400E-01 |
| Normal-vs-N2 |
5.466400E-02 |
| N0-vs-N1 |
9.092600E-01 |
| N0-vs-N2 |
4.437400E-01 |
| N1-vs-N2 |
4.511600E-01 |
|
|
